Article
Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate.
Journal of clinical pharmacology - 1 Jun 2012
Shroads Albert L, Langaee Taimour, Coats Bonnie S, Kurtz Tracie L, Bullock John R, Weithorn David, Gong Yan, Wagner David A, Ostrov David A, Johnson Julie A, Stacpoole Peter W
Abstract excerpt
Dichloroacetate (DCA), a chemical relevant to environmental science and allopathic medicine, is dehalogenated by the bifunctional enzyme glutathione transferase zeta (GSTz1)/maleylacetoacetate isomerase (MAAI), the penultimate enzyme in the phenylalanine/tyrosine catabolic pathway. The authors postulated that polymorphisms in GSTz1/MAAI modify the toxicokinetics of DCA. GSTz1/MAAI haplotype significantly affected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
